LUX-H&N1: Phase 3 trial of afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from The University of Chicago Medicine, Chicago, IL...
Author: EMJ
Added: 02/01/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Carcinoma | HNSCC | Methotrexate | Politics | Skin Cancer | Squamous Cell Carcinoma